Comparing Efficiency of Mirogabalin and Pregabalin in Primary TKA
Comparison Efficacy of Mirogabalin and Pregabalin in Total Knee Arthroplasty. a Randomized Controlled Trial
Thammasat University Hospital
80 participants
Apr 1, 2024
INTERVENTIONAL
Summary
The goal of this RCT is to compare efficacy between mirogabalin and pregabalin in pain reducing after unilateral primary total knee arthroplasty. The main question\[s\] it aims to answer are: • Does mirogabalin have better pain reduction than pregabalin after unilateral primary total knee arthroplasty. Participants will randomized to mirogabalin or pregabalin group and will take the drug for 6 weeks after TKA. Researchers will compare to pregabalin group to see pain and functional outcomes after TKA.
Eligibility
Inclusion Criteria3
- Age 50-85 years old
- Unilateral primary osteoarthritis undergoing primary TKA
- ASA I-III
Exclusion Criteria6
- GFR \<60
- Allergy to drug in this study
- Cannot underwent spinal anesthesia and adductor canal block
- Taking gabapentinoid within 3 months before surgery
- History of previous knee surgery
- Severe liver disease
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Participants will receive 5 mg of mirogabalin, taken as half a tablet, every day twice a day, after breakfast and dinner, for 6 weeks.
Participants will receive 50 mg of pregabalin, taken as a tablet, every day twice a day, after breakfast and dinner, for 6 weeks.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06328062